The evaluation of SAH remains controversial in patients with advanced liver abnormalities; the prevalence of manifestation in this group is low, even in cases of renovascular disease and high circulating renin activity; patients with established arterial hypertension may become normotensive during the progression of liver disease. The gene discussed is REN; the disease is liver disorder.